Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
Johnson & Johnson Submits Second NDA for Nipocalimab to Treat Generalized Myasthenia Gravis
October 13, 2024
Company
Drug
Keymed Biosciences’ IL-4Rα mAb Stapokibart Receives NMPA Approval for Atopic Dermatitis Treatment
October 13, 2024
Company
Policy / Regulatory
South Korea’s MFDS Aims to Slash Drug Approval Times with New Innovation Plan
October 13, 2024
Company
Deals
Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion
October 13, 2024
Company
Deals
Shanghai Bao Pharmaceutical and Subsidiary Secure Commercialization Rights Deal for SJ02 with Organon China
December 2, 2025
Company
Deals
ChemPartner Pharmatech Enters Strategic Partnership with Malaysian Entities to Develop Innovative Drugs
December 16, 2024
Company
Deals
Nona Biosciences and Umoja Biopharma Join Forces to Develop In Vivo CAR-T Therapies
October 13, 2024
Company
Deals
Beijing’s MoleculeMind Secures Series A Funding to Accelerate AI Protein Design Innovations
October 13, 2024
General/Other
Leadership Shuffle at China’s National Health Commission: Liu Jinfeng Steps in as Deputy Director
September 13, 2024
Company
Deals
Autobio Diagnostics Partners with MBL to Advance Microbial Mass Spectrometry Technology
October 13, 2024
Company
Medical Device
Yestar Healthcare’s 2024 Interim Report Reflects Impact of Volume-Based Procurement on Revenue
October 13, 2024
Company
Drug
Sanofi’s Dupixent Shows Promise in Phase III Trials for Rare Skin Disease and Chronic Hives
October 13, 2024
1
2
…
593
594
595
596
597
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?